SubjectWell has already registered the patients you need.
Tens of millions of patients, motivated by clinical research as a new care option, have already joined the SubjectWell marketplace with over 300,000 newly registering each month. These patients are unique: often new to clinical trials and always with known medical conditions. SubjectWell’s unmatched patient access covers more than 175 therapeutic areas, spanning 4 continents and with 47% of those registered self-reporting as people of color.
3,000+ patients screened every day
300,000+ patients registering monthly
47% people of color in the marketplace
Over 175 therapeutic areas
Enrolling patients on 4 continents
How it works
SubjectWell’s general awareness advertising finds a person interested in new treatment options.
The patient confirms their interest and conditions with SubjectWell.
Machine learning algorithms present trial and treatment options matching their conditions.
Patients choose the trial or treatment that is right for them.
A history of success with sponsor and CRO partners.
Since launching in 2012, SubjectWell has built the largest, direct patient access marketplace. We’ve helped over 10,000 patients randomize by working with over 11,000 sites. Ten years later, 18 of the top 20 pharmaceutical companies have used SubjectWell’s patient access to enroll their studies. Today, we offer a breadth of solutions both in support of enrolling patients in clinical research as well as building public awareness of market-ready treatments.